Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA.

Annu Rev Microbiol. 2005;59:587-635. Review.

PMID:
16153180
2.

Vaccine-derived polioviruses.

Burns CC, Diop OM, Sutter RW, Kew OM.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93. doi: 10.1093/infdis/jiu295. Review.

PMID:
25316847
3.

Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.

Pliaka V, Kyriakopoulou Z, Markoulatos P.

Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Review.

PMID:
22827246
4.

Circulating vaccine-derived polioviruses: current state of knowledge.

Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA.

Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Review.

6.

Risk management in a polio-free world.

Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D.

Risk Anal. 2006 Dec;26(6):1441-8. Review.

PMID:
17184391
7.

[End phase challenges of poliomyelitis eradication programme realization].

Jarzabek Z.

Przegl Epidemiol. 2005;59(1):59-68. Review. Polish.

PMID:
16013411
8.
9.

World wide experience with inactivated poliovirus vaccine.

Bonnet MC, Dutta A.

Vaccine. 2008 Sep 15;26(39):4978-83. doi: 10.1016/j.vaccine.2008.07.026. Epub 2008 Aug 3. Review.

PMID:
18680777
10.

Polio eradication: the OPV paradox.

Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ.

Rev Med Virol. 2003 Sep-Oct;13(5):277-91. Review.

PMID:
12931339
11.

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

Thompson KM, Tebbens RJ.

Expert Rev Vaccines. 2012 Apr;11(4):449-59. doi: 10.1586/erv.11.195. Review.

PMID:
22551030
12.

The polio endgame.

Minor P.

Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115. Review.

13.

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.

Minor P.

Vaccine. 2009 May 5;27(20):2649-52. doi: 10.1016/j.vaccine.2009.02.071. Epub 2009 Mar 3. Review.

PMID:
19428874
14.

[Eradication of poliomyelitis and emergence of pathogenic vaccine-derived polioviruses: from Madagascar to Cameroon].

Delpeyroux F, Colbère-Garapin F, Razafindratsimandresy R, Sadeuh-Mba S, Joffret ML, Rousset D, Blondel B.

Med Sci (Paris). 2013 Nov;29(11):1034-41. doi: 10.1051/medsci/20132911021. Epub 2013 Nov 20. Review. French.

15.

Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.

Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y.

Vaccine. 2015 Mar 3;33(10):1235-42. doi: 10.1016/j.vaccine.2015.01.018. Epub 2015 Jan 16. Review.

16.

[Universal use of inactivated poliovirus vaccine--the needs and challenges].

Shimizu H, Takeda N.

Nihon Rinsho. 2008 Oct;66(10):1950-5. Review. Japanese.

PMID:
18939495
17.

A case for developing antiviral drugs against polio.

Collett MS, Neyts J, Modlin JF.

Antiviral Res. 2008 Sep;79(3):179-87. doi: 10.1016/j.antiviral.2008.04.002. Epub 2008 May 13. Review.

PMID:
18513807
18.

Polio endgame: the global introduction of inactivated polio vaccine.

Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M.

Expert Rev Vaccines. 2015 May;14(5):749-62. doi: 10.1586/14760584.2015.1001750. Epub 2015 Jan 19. Review.

PMID:
25597843
19.

[Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].

Delpeyroux F, Guillot S, Szendröi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R.

Bull Soc Pathol Exot. 2000 Jul;93(3):193-7. Review. French.

PMID:
11030056
20.

[Worldwide eradication of poliomyelitis].

Rasch G, Schreier E, Kiehl W, Kurth R.

Wien Klin Wochenschr. 2001 Oct 30;113(20-21):839-45. Review. German.

PMID:
11732120

Supplemental Content

Support Center